Yahoo Web Search

Sign In

Search results

    • EU delays approval of Novavax's revised COVID vaccine - FT

      Reuters via Yahoo Finance· 6 months ago

      Oct 15 (Reuters) - European Union (EU) regulators have delayed the decision to give approval for Novavax's variant-tailored COVID-19 vaccine, the Financial Times said on Sunday. The European ...

    • 3 Reasons to Buy Novavax and 1 to Sell

      3 Reasons to Buy Novavax and 1 to Sell

      Motley Fool· 2 years ago

      Novavax (NASDAQ: NVAX) is a pandemic stock. Now it's down to $50, and the company's market cap is under $4 billion. Here are three arguments for buying...

    • The Window of Opportunity Has Closed for Novavax

      The Window of Opportunity Has Closed for Novavax

      InvestorPlace via Yahoo Finance· 2 years ago

      The Food and Drug Administration (FDA) will meet in June to determine approval for Novavax’s (NVAX) Covid-19 vaccine. The early rollout of it in the...